Medscape Conference Coverage, based on selected sessions at the:

European Respiratory Society (ERS) 2008 Annual Congress

October 04 - 08, 2008; Berlin, Germany

This activity is not sanctioned by, nor a part of, the European Respiratory Society. Conference news does not receive grant support and is produced independently.

Conference News

  • Pemetrexed Plus Cisplatin in Mesothelioma

    Results of 2 phase 3 trials indicate that combination therapy significantly prolongs survival in mesothelioma.
    Medscape Medical News, October 7, 2008
  • Extensively Drug-Resistant TB and Linezolid

    Extensively drug-resistant tuberculosis is an emerging disease with a very poor prognosis and limited response to existing treatments, including linezolid. The best second-line treatments have moderate efficacy and immoderately high toxicity.
    Medscape Medical News, October 7, 2008
  • Revascularization and Asymptomatic Sleep Apnea

    A randomized trial of continuous positive airway pressure in patients with coronary artery disease and obstructive sleep apnea reveals that an unexpectedly high percentage have no symptoms of daytime sleepiness.
    Medscape Medical News, October 6, 2008
  • Nocturnal Asthma Poorly Treated

    Two surveys of nearly 35,000 adults with asthma show that almost all patients were awakened at least once a month by asthma symptoms, and three quarters were awakened at least once a week.
    Medscape Medical News, October 6, 2008

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the European Respiratory Society. These materials and the related activity are not sanctioned by the European Respiratory Society or the commercial supporter of the conference and do not constitute an official part of that conference.